These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10378526)

  • 21. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
    Knowles MR; Paradiso AM; Boucher RC
    Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatitis and cystic fibrosis gene mutations.
    Choudari CP; Lehman GA; Sherman S
    Gastroenterol Clin North Am; 1999 Sep; 28(3):543-9, vii-viii. PubMed ID: 10503135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of a cAMP-stimulated chloride secretion in regenerating poorly differentiated airway epithelial cells by adenovirus-mediated CFTR gene transfer.
    Dupuit F; Chinet T; Zahm JM; Pierrot D; Hinnrasky J; Kaplan H; Bonnet N; Puchelle E
    Hum Gene Ther; 1997 Aug; 8(12):1439-50. PubMed ID: 9287144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis.
    Wagner JA; Moran ML; Messner AH; Daifuku R; Conrad CK; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Hum Gene Ther; 1998 Apr; 9(6):889-909. PubMed ID: 9581911
    [No Abstract]   [Full Text] [Related]  

  • 25. A missed cystic fibrosis diagnosis in childhood.
    Leonardi S; Sciuto C; La Rosa M
    Allergy Asthma Proc; 2005; 26(6):487-8. PubMed ID: 16541975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
    Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
    J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
    Kuk K; Taylor-Cousar JL
    Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of radiographic and clinical characteristics of low-risk and high-risk cystic fibrosis genotypes.
    Ferril GR; Nick JA; Getz AE; Barham HP; Saavedra MT; Taylor-Cousar JL; Nichols DP; Curran-Everett D; Kingdom TT; Ramakrishnan VR
    Int Forum Allergy Rhinol; 2014 Nov; 4(11):915-20. PubMed ID: 25224556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.
    Kinnman N; Lindblad A; Housset C; Buentke E; Scheynius A; Strandvik B; Hultcrantz R
    Hepatology; 2000 Aug; 32(2):334-40. PubMed ID: 10915740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic fibrosis transmembrane regulator potentiators as promising cystic fibrosis therapies.
    Antoniu SA
    Expert Opin Investig Drugs; 2011 Mar; 20(3):423-5. PubMed ID: 21303308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhinosinusitis in the pediatric patient with cystic fibrosis.
    Fundakowski C; Ojo R; Younis R
    Curr Pediatr Rev; 2014; 10(3):198-201. PubMed ID: 25088340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early bronchial inflammation in cystic fibrosis].
    Puchelle E
    J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.
    Clancy JP; Bebök Z; Ruiz F; King C; Jones J; Walker L; Greer H; Hong J; Wing L; Macaluso M; Lyrene R; Sorscher EJ; Bedwell DM
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1683-92. PubMed ID: 11401894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis: experience in one institution.
    Liu LC; Shyur SD; Chu SH; Huang LH; Kao YH; Lei WT; Cheng CH; Lo CY; Chen CK; Fang LC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):358-61. PubMed ID: 22992393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.
    Dormer RL; Harris CM; Clark Z; Pereira MM; Doull IJ; Norez C; Becq F; McPherson MA
    Thorax; 2005 Jan; 60(1):55-9. PubMed ID: 15618584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands.
    Jacquot J; Puchelle E; Hinnrasky J; Fuchey C; Bettinger C; Spilmont C; Bonnet N; Dieterle A; Dreyer D; Pavirani A
    Eur Respir J; 1993 Feb; 6(2):169-76. PubMed ID: 7680322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis and related diseases of the pancreas.
    Naruse S; Kitagawa M; Ishiguro H; Fujiki K; Hayakawa T
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):511-26. PubMed ID: 12079272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simplified cyclic adenosine monophosphate-mediated sweat rate test for quantitative measure of cystic fibrosis transmembrane regulator (CFTR) function.
    Callen A; Diener-West M; Zeitlin PL; Rubenstein RC
    J Pediatr; 2000 Dec; 137(6):849-55. PubMed ID: 11113843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.